New treatments in non-infectious uveitis / / volume editors, Elisabetta Miserocchi, Giulio Modorati, C. Stephen Foster

• Record Nr.: UNINA9910163131103321
• Pubbl/distr/stampa: Basel : , : Karger, , [2012]; ©2012
• ISBN: 1-280-67107-6; 9786613648006; 3-8055-9987-0
• Descrizione fisica: 1 online resource (179 p.)
• Collana: Developments in ophthalmology, , 0250-3751 ; ; volume 51
• Altri autori (Persone): MiserocchiElisabetta; ModoratiGiulio; FosterC. Stephen <1942-> (Charles Stephen)
• Disciplina: 617.7/2
• Soggetti: Uveitis - Gene therapy
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: The philosophy of treatment of uveitis : past, present and future / Kruh, J., Foster, C.S. -- The gold standard of noninfectious uveitis : corticosteroids / Lehoang, P. -- Corticosteroid-sparing agents : conventional systemic immunosuppressants / Kruh, J., Foster, C.S. -- Corticosteroid-sparing agents : new treatment options / Tomkins-Netzer, O., Taylor, S.R.J., Lightman, S. -- Mycophenolate mofetil use in the treatment of noninfectious uveitis / Klisovic, D.D. -- Anti-tumor necrosis factor : agents in noninfectious uveitis / Gueudry, J., LeHoang, P., Bodaghi, B. -- New biologic drugs : anti-interleukin therapy -- Tappeiner, C. ... [et al.] -- Interferon / Deuter, C., Stübiger, N., Zierhut, M. -- Rituximab for the treatment of noninfectious uveitis / Miserocchi, E., Modorati, G. -- Intravitreal injection therapy in the treatment of noninfectious uveitis / Modorati, G., Miserocchi, E. -- Corticosteroid intravitreal implants / de Smet, M.D. -- New treatment options for noninfectious uveitis / Gomes Bittencourt, M. ... [et al.].
• Sommario/riassunto: Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic ; armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.